- Home
- CMCM vs TARA Comparison
CMCM vs TARA Comparison
Compare CMCM & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCM
- TARA
- Stock Information
- Founded
- CMCM 2009
- TARA N/A
- Country
- CMCM China
- TARA United States
- Employees
- CMCM N/A
- TARA N/A
- Industry
- CMCM Computer Software: Prepackaged Software
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCM Technology
- TARA Health Care
- Exchange
- CMCM Nasdaq
- TARA Nasdaq
- Market Cap
- CMCM 115.1M
- TARA 126.5M
- IPO Year
- CMCM 2014
- TARA N/A
- Fundamental
- Price
- CMCM $4.62
- TARA $3.00
- Analyst Decision
- CMCM
- TARA Strong Buy
- Analyst Count
- CMCM 0
- TARA 7
- Target Price
- CMCM N/A
- TARA $20.67
- AVG Volume (30 Days)
- CMCM 24.5K
- TARA 489.6K
- Earning Date
- CMCM 06-19-2025
- TARA 08-05-2025
- Dividend Yield
- CMCM N/A
- TARA N/A
- EPS Growth
- CMCM N/A
- TARA N/A
- EPS
- CMCM N/A
- TARA N/A
- Revenue
- CMCM $120,663,543.00
- TARA N/A
- Revenue This Year
- CMCM $14.27
- TARA N/A
- Revenue Next Year
- CMCM $39.26
- TARA N/A
- P/E Ratio
- CMCM N/A
- TARA N/A
- Revenue Growth
- CMCM 27.02
- TARA N/A
- 52 Week Low
- CMCM $3.02
- TARA $1.60
- 52 Week High
- CMCM $6.77
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- CMCM 67.42
- TARA 40.33
- Support Level
- CMCM $4.53
- TARA $2.77
- Resistance Level
- CMCM $4.90
- TARA $3.10
- Average True Range (ATR)
- CMCM 0.19
- TARA 0.17
- MACD
- CMCM 0.05
- TARA -0.01
- Stochastic Oscillator
- CMCM 89.80
- TARA 8.00
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).